Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Oxidative Stress
2017 Standout
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
2014
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
Acidic extracellular microenvironment and cancer
2013
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Systematic pan-cancer analysis of tumour purity
2015
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
2017 Standout
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
2014
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
The novel targets for anti-angiogenesis of genistein on human cancer cells
2004
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
2015
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Ovarian cancer
2014 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
2015
Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy
2015
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
xCell: digitally portraying the tissue cellular heterogeneity landscape
2017 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
2015
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
2018
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis
2010
Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer
2004
The impact of T‐cell immunity on ovarian cancer outcomes
2008
Single Nucleotide Polymorphisms within Interferon Signaling Pathway Genes Are Associated with Colorectal Cancer Susceptibility and Survival
2014
Maspin is an angiogenesis inhibitor
2000 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells
2011
Multi-targeted therapy of cancer by genistein
2008 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
2009
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
2008
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Correlation of Vascular Endothelial Growth Factor Expression and Microvessel Density in Cervical Intraepithelial Neoplasia
1997
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
2014 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Fibroblasts in cancer
2006 Standout
Polycystic ovary syndrome
2016 Standout
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
2011
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
2016
Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling
2013
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2
2015
International Statistical Classification of Diseases and Related Health Problems
2014 Standout
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
2019 StandoutNobel
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
2009
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Combination therapy in combating cancer
2017 Standout
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
2009
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
2016
Immunogenic Cell Death in Cancer Therapy
2012 Standout
2017
Works of Suha Deen being referenced
Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
2008
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
2014
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
2012
Basement membrane and extracellular interstitial matrix components in bladder neoplasia—evidence of angiogenesis
1994
The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression
2011
Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help?
2013
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
2012
Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival
2012
Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy
2010
Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy
2009
T Cell Density and Location Can Influence the Prognosis of Ovarian Cancer
2009
Predictors of the location of multiple sclerosis relapse
2008
Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer
2007
Loss of IFNγ Receptor Is an Independent Prognostic Factor in Ovarian Cancer
2007